Sensei Biotherapeutics Inc. (NASDAQ: SNSE) Stock Information | RedChip

Sensei Biotherapeutics Inc. (NASDAQ: SNSE) Listen to this Section


$0.63
+0.0250 ( +4.11% ) 15.0K

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.

Market Data


Open


$0.63

Previous close


$0.61

Volume


15.0K

Market cap


$15.47M

Day range


$0.58 - $0.63

52 week range


$0.51 - $1.94

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Apr 12, 2024
8-k 8K-related 13 Apr 02, 2024
8-k 8K-related 16 Mar 05, 2024
10-k Annual reports 98 Feb 29, 2024
8-k 8K-related 16 Feb 28, 2024
4 Insider transactions 1 Feb 16, 2024
4 Insider transactions 1 Feb 16, 2024
4 Insider transactions 1 Feb 16, 2024
8-k 8K-related 15 Feb 08, 2024
8-k 8K-related 56 Jan 04, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.